Changes in serum levels of pain mediators in hemiplegic shoulder pain
Brain and Behavior · 2023
DOI: 10.1002/brb3.3289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2023. Verfasst von Mincong Lei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rehabilitation Center, The first Affiliated Hospital with Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Shoulder Pain, Stroke. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Province Key R&D Program Projects.
Abstract (Originalsprache)
Objective
To provide a new insight into the diagnosis and treatment of hemiplegic shoulder pain (HSP) by investigating changes in serum pain mediators.
Design
Cross‐sectional study. Subjects/patients Shoulder pain group ( n = 34) and control group ( n = 21).
Methods
Pain‐free shoulder mobility, anxiety status, depression status, and shoulder pain were measured by passive range of motion (PROM), self‐rating anxiety scale, self‐rating depression scale (SDS), and visual analog scale, respectively. The enzyme‐linked immunosorbent assay was used to test the serum pain mediators, including interleukin (IL)‐1β, IL‐2, IL‐6, IL‐10, nerve growth factor (NGF), tumor necrosis factor‐α (TNF‐α), substance P (SP), calcitonin gene‐related peptide (CGRP), bradykinin (BK), 5‐hydroxytryptamine (5‐HT), prostaglandin E2 (PGE2), and lysophosphatidic acid (LPA).
Results
Shoulder pain group pain‐free PROM significantly lower than control ( p < .01), and SDS index score of shoulder pain group was significantly higher than control ( p < .05). The rate of spasticity in the flexor elbow muscles is higher in shoulder pain group ( p < .01). CGRP, IL‐10, and IL‐2 were significantly upregulated in shoulder pain group compared with control ( p < .01), whereas NGF, TNF‐α, IL‐6, 5‐HT, PGE2, SP, LPA, BK, and IL‐1β were significantly decreased ( p < .01).
Conclusion
Patients with HSP have a higher risk of joint mobility disorders and depression; spasticity may be an important factor in the development of shoulder pain; CGRP is thought to be the major pain mediator in HSP, and HSP may not be inflammatory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rehabilitation Center, The first Affiliated Hospital with Nanjing Medical University, Nanjing, China.
- Children's Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, China.
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
- Department of Rehabilitation Medicine, Nanjing Qixia District Hospital, Nanjing, China.
- The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Mincong Lei, Dianhuai Meng
Förderung
- Jiangsu Province Key R&D Program Projects
Zitieren
APA
Lei, M., Wang, Y., Chen, Q., Huang, P., Li, Y., Jia, Y., & Meng, D. (2023). Changes in serum levels of pain mediators in hemiplegic shoulder pain. Brain and Behavior. https://doi.org/10.1002/brb3.3289
Vancouver
Lei M, Wang Y, Chen Q, Huang P, Li Y, Jia Y, et al. Changes in serum levels of pain mediators in hemiplegic shoulder pain. Brain and Behavior. 2023. doi:10.1002/brb3.3289
BibTeX
@article{Lei2023,
author = {Lei, Mincong and Wang, Yidi and Chen, Qian and Huang, Peng and Li, Yige and Jia, Yuanyuan and Meng, Dianhuai},
title = {Changes in serum levels of pain mediators in hemiplegic shoulder pain},
journal = {Brain and Behavior},
year = {2023},
doi = {10.1002/brb3.3289}
}
EUVIMED